Importance of molecular shape for the overall stability of hydrogen bond motifs in the crystal structures of various carbamazepine-type drug molecules

被引:50
作者
Cruz Cabeza, Aurora J.
Day, Graeme M.
Motherwell, W. D. Samuel
Jones, William
机构
[1] Univ Cambridge, Dept Chem, Pfizer Inst Pharmaceut Mat Sci, Cambridge CB2 1EW, England
[2] Cambridge Crystallog Data Ctr, Cambridge CB2 1EZ, England
关键词
D O I
10.1021/cg060504u
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Carbamazepine, a first generation anticonvulsant, is known to crystallize in various polymorphic forms, all of which exhibit an anti-carboxamide hydrogen bond dimer motif. Furthermore, unless cocrystallized with carboxylic acids, these dimers are also present in most crystal structures of the known carbamazepine solvates. On the other hand, two derivatives of the drug (oxcarbazepine and 10,11-dihydrocarbamazepine) have been reported to adopt hydrogen bond chain motifs in their crystal structures, whereas the epoxy derivative (10,11-epoxycarbamazepine) shows a third mode of hydrogen bonding, syn-dimers. In order to rationalize the differences in hydrogen bonding caused by the small changes in molecular structure, computational searches for the low-energy crystal structures of these drugs were performed and hydrogen bond patterns in both the hypothetical and experimentally determined crystal structures were analyzed. In addition, interaction energies between pairs of molecules were calculated using the SCDS-PIXEL approach, which partitions the intermolecular interaction energy into its different contributions (Coulombic, polarization, dispersion, and repulsion). The importance of overall molecular shape and the influence that this has on the hydrogen bond arrangements in these structures is emphasized.
引用
收藏
页码:100 / 107
页数:8
相关论文
共 46 条
[1]  
*ACC INC, 2004, MS MOD REL 3 0 1
[2]  
*ACC INC A, 1997, CER VERS 4 6
[3]   The Cambridge Structural Database: a quarter of a million crystal structures and rising [J].
Allen, FH .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 2002, 58 (3 PART 1) :380-388
[4]  
AMOS RD, 1995, CADPAC VERSION 6 0
[5]   X-RAY CRYSTALLOGRAPHIC CHARACTERIZATION OF 10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE [J].
BANDOLI, G ;
NICOLINI, M ;
ONGARO, A ;
VOLPE, G ;
RUBELLO, A .
JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1992, 22 (02) :177-183
[6]   Ritonavir: An extraordinary example of conformational polymorphism [J].
Bauer, J ;
Spanton, S ;
Henry, R ;
Quick, J ;
Dziki, W ;
Porter, W ;
Morris, J .
PHARMACEUTICAL RESEARCH, 2001, 18 (06) :859-866
[7]  
BELLUCCI G, 1995, GAZZ CHIM ITAL, V125, P341
[8]  
Bernstein J., 2020, Polymorphism in Molecular Crystals, Vsecond, DOI 10.1093/oso/9780199655441.001.0001
[9]   Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development [J].
Chemburkar, SR ;
Bauer, J ;
Deming, K ;
Spiwek, H ;
Patel, K ;
Morris, J ;
Henry, R ;
Spanton, S ;
Dziki, W ;
Porter, W ;
Quick, J ;
Bauer, P ;
Donaubauer, J ;
Narayanan, BA ;
Soldani, M ;
Riley, D ;
McFarland, K .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) :413-417
[10]   COMPACK:: a program for identifying crystal structure similarity using distances [J].
Chisholm, JA ;
Motherwell, S .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2005, 38 :228-231